 |
 |
i am astounded! shocked! that such a misstatement could show up on this list. If one takes the time to read the abstract of the study results, one finds specific positive results and the following summary: 1: N Engl J Med. 2009 Sep 24;361(13):1268-78 CONCLUSIONS: Early treatment with rasagiline at a dose of 1 mg per day provided benefits that were consistent with a possible disease-modifying effect, but early treatment with rasagiline at a dose of 2 mg per day did not. Because the two doses were associated with different outcomes, the study results must be interpreted with caution. (ClinicalTrials.gov number, NCT00256204.) 2009 Massachusetts Medical Society) see: http://www.ncbi.nlm.nih.gov/pubmed/19776408 > Date: Thu, 1 Oct 2009 21:23:12 -0700 > From: [log in to unmask] > Subject: THE EFFECT OF RASAGILINE ON PARKINSON'S DISEASE > To: [log in to unmask] > > Rayilyn Brown > Director AZNPF > Arizona Chapter National Parkinson Foundation > [log in to unmask] > > > From: Diane Wyshak > Sent: Thursday, October 01, 2009 11:26 AM > To: ray ; chew Nee Kong > Subject: THE EFFECT OF RASAGILINE ON PARKINSON'S DISEASE > > > > http://www.viartis.net/parkinsons.disease/news/091001.htm > > ---------------------------------------------------------------------- ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn